You are here

Vor Biopharma

Trials to watch: CRISPR pipeline accelerates after milestone Casgevy approval

Clinical Trials Arena

Wed, 01/17/24 - 09:30 am

clinical trials

Vertex Pharmaceuticals

CRISPR Therapeutics

Shanghai Vitalgen BioPharma

Vor's cancer cell therapy gets on FDA fast track ahead of 2022 data drop

Fierce Biotech

Sat, 09/11/21 - 10:28 pm

J&J, Vor ally to assess bispecific and stem cell therapy in AML

Fierce Biotech

Fri, 07/9/21 - 10:13 am

bispecific antibodies

stem cell therapy

IPO tracker: 2021 gets started with a flurry of new offerings

Endpoints

Mon, 01/25/21 - 10:43 am

Sana Biotechnology

Sensei Biotherapeutics

Bolt Biotherapeutics

Terns Pharmaceuticals

Gracell Biotechnologies

Cullinan Oncology

Vor Biopharma Snags $110 Million to Advance AML Treatment into the Clinic

BioSpace

Tue, 07/7/20 - 08:04 pm

clinical trials